Structure of tumor necrosis factor and its receptor (original) (raw)
References
O'Malley WE, Achinstein B, Shear MJ. Action of bacterial polysaccharide on tumors. II. Damage of sarcoma 37 by serum of mice treated with_Serratia marcescens_ polysaccharide, and induced tolerance. J Natl Cancer Inst 1962; 29: 1169–75. Google Scholar
Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975; 72: 3666–70. PubMed Google Scholar
Matthews N. Tumour necrosis factor from the rabbit. II. Production by monocytes. Br J Cancer 1978; 38: 310–5. PubMed Google Scholar
Aggarwal BB, Kohr WJ, Hass PE, Mofat B, Spencer SA, Henzel WJ, Bringman TS, Nedwin GE, Goeddel DV, Harkins RN. Human tumor necrosis factor: production, purification, and characterization. J Biol Chem 1985; 260: 2345–54. PubMed Google Scholar
Beutler B, Mahoney J, Le Trang N, Pekala P, Cerami A. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced raw 264.7 cells. J Exp Med 1985; 161: 984–95. PubMed Google Scholar
Haranaka K, Carswell EA, Williamson, BD, Prendergast JS, Satomi N, Old, LJ. Purification, characterization, and antitumor activity of nonrecombinant mouse tumor necrosis factor. Proc Natl Acad Sci USA 1986; 83: 3949–53. PubMed Google Scholar
Kull FC, Cuatrecasas P. Necrosin: purification and properties of a cytotoxin derived from a murine macrophagelike cell line. Proc Natl Acad Sci USA 1984; 81: 7932–6. PubMed Google Scholar
Abe S, Gatanaga T, Yamazaki M, Soma Gen'ichior, Mizuno Den'ichi. Purification of rabbit tumor necrosis factor. FEBS Lett 1985; 180: 203–6. PubMed Google Scholar
Rubin BY, Anderson SL, Sullivan SA, Williamson BD, Carswell EA, Old LJ. Purification and characterization of a human tumor necrosis factor from the LuKII cell line. Proc Natl Acad Sci USA 1985; 82: 6637–41. PubMed Google Scholar
Hahn T, Toker L, Budilovsky S, Aderka D, Eshhar Z, Wallach D. Use of monoclonal antibodies to a human cytotoxin for its isolation and for examining the self-induction of resistance to this protein. Proc Nall Acad Sci USA 1985; 82: 3814–18. Google Scholar
Tamatani T, Kimura S, Hashimoto T, Onozaki K. Purification of guinea pig tumor necrosis factor (TNF): comparison of its antiproliferative and differentative activities for myeloid leukemic cell lines with those of recombinant human TNF. J Biochem 1989; 105: 55–60. PubMed Google Scholar
Adams B, Regenass U, Cerletti N. An efficient method for the purification of tumor necrosis factor from rabbit serum. Lymphokine Res 1987; 6: 203–14. PubMed Google Scholar
Haranaka K, Satomi N, Sakurai A, Nariuchi H. Purification and partial amino acid sequence of rabbit tumor necrosis factor. Int J Cancer 1985; 36: 395–400. PubMed Google Scholar
Davis JM, Narachi MA, Alton NK, Arakawa T. Structure of human tumor necrosis factor_α_ derived from recombinant DNA. Biochemistry 1987; 26: 1322–6. PubMed Google Scholar
Narhi LO, Arakawa T. Dissociation of recombinant tumor necrosis factor_α_ studied by gel permeation chromatography. Biochem Biophys Res Commun 1987; 147: 740–6. PubMed Google Scholar
Arakawa T, Yphantis DA. Molecular weight of recombinant human tumor necrosis factor-α. J Biol Chem 1987; 262: 7484–5. PubMed Google Scholar
Wingfield P, Pain RH, Craig S. Tumor necrosis factor is a compact trimer. FEBS Lett 1987; 211: 179–84. PubMed Google Scholar
Pennica D, Hayfiick JS, Bringman TS, Palladino MA, Goeddel DV. Cloning and expression in_Escherichia coli_ of the cDNA for murine tumor necrosis factor. Proc Natl Acad Sci USA 1985; 82: 6060–4. PubMed Google Scholar
Goeddel DV, Aggarwal BB, Gray PW, Leung DW, Nedwin GE, Palladino MA, Patton JS, Pennica D, Shepard HM, Sugarman BJ, Wong, GHW. Tumor necrosis factors: gene structure and biological activities in Cold Spring Harbor Symposia on Quantitative Biology, Vol. Ll, 1986, 597–609. Google Scholar
Lewit-Bentley, A, Fourme R, Kahn R, Prang & T, VachetteP, Tavernier J, Hauquier G, Fiers W. Structure of tumor necrosis facto fn by x-ray solution scattering and preliminary studies by single crystal x-ray diffraction. J Mol Biol 1988; 199: 389–92. PubMed Google Scholar
Jones EY, Stuart DI, Walker NPC. Structure of tumour necrosis factor. Nature 1989; 338: 225–8. PubMed Google Scholar
Eck MJ, Sprang SR. The structure of tumor necrosis factor-α at 2.6 Å resolution: implications for receptor binding. J Biol Chem 1989; 264: 17595–605. PubMed Google Scholar
Eck MJ, Beutler B, Kuo G, Merryweather JP, Sprang SR. Crystallization of trimeric recombinant human tumour necrosis factor (Cachectin). J Biol Chem 1988; 263: 12816–19. PubMed Google Scholar
Smith RA, Baglioni C. The active form of tumor necrosis factor is a trimer. J Biol Chem 1987; 262: 6951–4. PubMed Google Scholar
Petersen CM, Nykjaer A, Christiansen BS, Heickendorff L, Mogensen SC, Moller B. Bioactive human recombinant tumor necrosis factor-α: an unstable dimer? Eur J Immunol 1989; 19: 1887–94. PubMed Google Scholar
Aggarwal BB, Eessalu, TE. Induction of receptors for tumor necrosis factor-α by interferons is not a major mechanism for their synergistic cytotoxic response. J Biol Chem 1987; 262: 10,000–7. Google Scholar
Carlino JA, Lin LS, Creasey AA. Use of a sensitive receptor binding assay to discrimanate between full-length and truncated human recombinant tumor necrosis factor proteins. J Biol Chem 1987; 262: 958–61. PubMed Google Scholar
Creasey AA, Doyle LV, Reynolds MT, Jung T, Lin LS, Vitt CR. Biological effects of recombinant human tumor necrosis factor and its novel muteins on tumor and normal cell lines. Cancer Res 1987; 47: 145–9. PubMed Google Scholar
Bringman TS, Aggarwal BB. Monoclonal antibodies to human tumor necrosis factors alpha and beta: application for affinity purification, immunoassays and as structural probes. Hybridoma 1987; 6: 489–507. PubMed Google Scholar
Socher SH, Riemen MW, Martinez D, Friedman A, Tai J, Quinitero JC, Garsky V, Olif A. Antibodies against amino acids 1-15 of tumor necrosis factor block its binding to cell-surface receptor. Proc Natl Acad Sci USA 1987; 84: 8829–33. PubMed Google Scholar
Narachi MA, Davis JM, Hsu Y-R, Arakawa T. Role of single disulfide in recombinant human tumor necrosis factor-α. J Biol Chem 1987; 262: 13107–10. PubMed Google Scholar
Yamamoto R, Wang A, Vitt CR, Lin LS. Histidine-15. An important role in the cytotoxic activity of human tumor necrosis factor. Protein Engg 1989; 2: 553–8. Google Scholar
Van Ostad X, Tavernier J, Fiers W. Two conserved tryptophan residues of tumour necrosis factor and lymphotoxin are not involved in the biological activity. FEBS Lett 1988; 238: 347–52. PubMed Google Scholar
CsehK, BeutlerB. Alternative cleavage of the cachectin/ tumor necrosis factor propeptide results in a larger, inactive form of secreted protein. J Biol Chem 1989; 264: 16256–60. PubMed Google Scholar
Sugarman BJ, AggarwalBB, Hass PE, Fiari IS, Palladino MA Jr., Shepard HM. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science 1985; 230: 943–5. PubMed Google Scholar
Aggarwal BB, Eessalu TE, Hass PE Characterization of receptors for human tumor necrosis factor and their regulation by gamma-interferon. Nature 1985; 318: 665–7. PubMed Google Scholar
Patton JS, Shepard HM, Wilking H, Lewis G, Aggarwal BB, Eessalu TE, Gavin LA, Grunfeld C. Interferons and tumor necrosis factors have similar catabolic effects on 3T3 Ll cells. Proc Natl Acad Sci USA 1986; 83: 8313–7. PubMed Google Scholar
Aiyer, RA, Aggarwal BB. Tumor necrosis factors In: Podack ER, ed. CRC handbook on cytolytic lymphocytes and complement: effectors of the immune system. Boca Raton, FL: CRC Press Inc., 1988: 105–32. Google Scholar
Kramer SM, Aggarwal BB, Eessalu TE, McCabe SM, Figari IS, Ferraiolo BL, Palladino MA, Characterization of the_in vitro_ and_in vivo_ species preference of human and murine tumor necrosis factor-α. Cancer Res 1988; 48: 920–5. PubMed Google Scholar
Stauber GB, Aggarwal BB. Characterization and affinity cross linking of receptors for human recombinant lymphotoxin (TNF-β) on a human histiocytic lymphoma cell line U937. J Biol Chem 1989; 264: 3573–6. PubMed Google Scholar
Locksley RM, Heinzel FB, Shepard HM, Agosti J. Eessalu TE, Aggarwal BB, Harlan JM. Tumor necrosis factor-α and -β differ in their capacities to generate Interleukin-I release from human endothelial cells. J Immunol 1985; 139: 1891–5. Google Scholar
Nedosparov SA, Seregina TM, Meshenkov MI, Turetskaya RL. Lymphotoxin as an autocrine growth factor for a human lymphoblastoid B-cell line. In: 2nd international conference on tumor necrosis factor and related cytokines. Napa, California, January 15–20, 1989, Abstract No. WA-209.
Oster W, Lindemann A, Horn S, Mertelsmann R, Herrmann F. Tumor necrosis factor-α and not TNF-β induces secretion of colony-stimulating factor for macrophages (CSF-1) by human monocytes. Blood 1987; 70: 1700–3. PubMed Google Scholar
Desch CE, Dobrina A, Aggarwal BB, Harlan JM. Tumor necrosis factor-alpha exhibits greater proinflammatory activity than lymphotoxin in vitro. Submitted to Blood.
Stauber GB, Aiyer RA, Aggarwal BB. Human tumor necrosis factor receptor: purification by immunoaffinity chromatography and initial characterization. J Biol Chem 1988; 263: 19098–104. PubMed Google Scholar
Brockhaus M, Schoenfeld H-J, Schlaeger E-J, Hunziker W, Lesslauer W, Loetscher H. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 1990; 87: 3127–31. PubMed Google Scholar
Stauber GB, Aggarwal BB. Tumor necrosis factor and lymphotoxin are multipotential cytokines. In: Kotyk A, ed. Proceeding of the 14th international congress of biochemistry, 1989.
Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cossman D, Goodwin RG. A receptor for tumor necrosis factor defines an unusual family of cellular and viral problems. Science 1990; 248: 1019–23. PubMed Google Scholar
Peetre C, Thysell H, Grubb A, Olsson I. A tumor necrosis factor binding protein is present in human biological fluids. Eur J Haematol 1988; 41: 414–9. PubMed Google Scholar
Olsson I, Lantz M, Nilsson E, Peetre C, Thysell H, Grubb A, Adolf G. Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur J Haematol 1989; 42: 270–5. PubMed Google Scholar
Seckinger P, Isaaz S, Dayer J-M. Purification and biologic characterization of a specific tumor necrosis factor_α_ inhibitor. J Biol Chem 1989; 264: 11966–73. PubMed Google Scholar
Engelmann H, Aderka D, Rubinstein M, Rotman D, Wallack D. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem 1989; 264: 11974–80. PubMed Google Scholar
Engelmann H, Holtmann H, Brakebusch C, Shemer Avni Y, Sarov I, Nophar Y, Wallach D. Soluble forms of the TNF receptors, purified from human urine inhibit TNF effects. Antibodies against the soluble receptors induce TNF-like effects. Cytokine 1989; 1: 148A. Google Scholar
Hohmann H-P, Remy R, Brockhaus M, van Loon APGM. Two different cell types have different major receptors for human tumor necrosis factor (TNF_α_). J Biol Chem 1989; 14927-34.
Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, Wong GHW, Gatanaga T, Granger GA, Lentz R, Raab H, Kohr WJ, Goeddel DV. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 1990; 61: 361–70. PubMed Google Scholar
Loetscher H, Pan Y-CE, Lahm H-W, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 1990; 61: 351–9. PubMed Google Scholar